Tobias Speck

Title: **Tobias Speck: Innovator in Immunovirotherapy**

Introduction

Tobias Speck is a prominent inventor hailing from Bretten, Germany, known for his significant contribution to the field of immunovirotherapy. His work centers on innovative treatments for cancer using recombinant viruses.

Latest Patents

One of Tobias Speck's notable patents is the invention of RNA viruses for immunovirotherapy. This patent focuses on a recombinant virus from the Paramyxoviridae family that includes at least one expressible polynucleotide. This polynucleotide encodes a multispecific binding polypeptide featuring a binding domain that targets immune cells with antitumor activity, specifically lymphocytes such as T cells or dendritic cells, coupled with another domain that binds to tumor-associated antigens. The patent also describes a method for treating cancer, wherein the recombinant virus is introduced to patients afflicted by the disease, thereby providing a novel avenue for cancer therapy.

Career Highlights

Throughout his career, Tobias Speck has contributed his expertise to notable institutions such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Ruprecht-Karls-University Heidelberg. His experiences in these prestigious organizations have shaped his innovative approach and made significant impacts on cancer research.

Collaborations

During his professional journey, Tobias has collaborated with esteemed colleagues, including Guy Ungerechts and Christine Engeland. These partnerships have played an essential role in advancing research and fostering innovation in the field of immunovirotherapy.

Conclusion

Tobias Speck’s contributions to the realm of cancer treatment through his inventive work with RNA viruses underscore the potential for innovative approaches in medical science. His achievements and collaborations highlight a commitment to improving patient outcomes and advancing therapeutic options in oncology.